Joanna Boncela

15PUBLICATIONS
30CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersOrthopticsMolecular targetsChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 20, 2026
Bis-(di-4-phenyl-benzylaminethiocarbonyl)disulfide sensitizes ABCC2/ALDH3A1 overexpressing NSCLC cells to cisplatin.

|Aug 20, 2025
A preliminary bioinformatic screen to identify SRI SMC2 PSIP1 TLE4 and MSX1 as potential diagnostic and prognostic markers of osteoarthritis.

Jolanta Kryczka, Ewa Brzeziańska-Lasota, Michał Pikuła

|Feb 26, 2025
The Expression Level of SOX Family Transcription Factors' mRNA as a Diagnostic Marker for Osteoarthritis.

Kamila Baran, Ewa Brzeziańska-Lasota, Jakub Kryczka

|Nov 27, 2024
Radial Data Visualization-Based Step-by-Step Eliminative Algorithm to Predict Colorectal Cancer Patients' Response to FOLFOX Therapy.

Jakub Kryczka, Rafał Adam Bachorz, Jolanta Kryczka

|Dec 09, 2023
Characteristics of ABCC4 and ABCG2 High Expression Subpopulations in CRC-A New Opportunity to Predict Therapy Response.

Jakub Kryczka, Joanna Boncela

|Sep 28, 2023
The Comparison of Serum Exosome Protein Profile in Diagnosis of NSCLC Patients.

Kamila Baran, Joanna Waśko, Jakub Kryczka

Pageof 3

Frequent Collaborators

7 joint publications

Jakub Mateusz Kryczka

5 joint publications

Ewa Brzeziańska-Lasota

4 joint publications

Patrycja Przygodzka

4 joint publications

Jolanta Kryczka